Acorda Therapeutics
在场
Acorda Therapeutics 是一家在股票代码 ACOR (US) 下上市的公司。
高管
查看带有其 10 名主要高管的组织结构图
Acorda Therapeutics 搜索最多的简介
- Ron Cohen, President, Chief Executive Officer and Director
- Sandra Panem, Director
- Tom Burns, Director
高管在Acorda Therapeutics变化
- Tom Burns已作为Director加入公司 (新闻发布的2023六月29号).
创建提醒
跟踪 Acorda Therapeutics 的高管变动
生物技术
Acorda Therapeutics 拥有 2,237 家竞争者，其中包括 Adaptive Phage Therapeutics (美国(美洲))、Eurofins (卢森堡) 和 Lonza (瑞士)。
Popular M&A news in 生物技术
- Artbio 刚刚宣布为 90 筹款数百万美元。 (公布2023十二月8号).
- Roche has announced the acquisition of Carmot Therapeutics (公布2023十二月7号).
- Seismic Therapeutic 刚刚宣布为 121 筹款数百万美元。 (公布2023十二月7号).
生物技术 行业的其他推荐联系人
消息
Acorda Therapeutics 的最新新闻稿
- Acorda Therapeutics Reports Second Quarter 2023 Financial Results
- Tom Burns Elected to the Acorda Therapeutics Board of Directors
- Acorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price Requirement
- Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Acorda Therapeutics Inc - Investors - Investor News
- Acorda Therapeutics Inc Press Releases Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Offering AgreementAcorda Thera
- Acorda Corporate News and Information on Biotech Stocks | Acorda.com
- View more press releases Close
通过电子邮件
